Welcome to Psychiatryai.com: Latest Evidence - RAISR4D

Candidate Clinico-Demographic Predictors or Moderators of Efficacy and Tolerability of Pharmacological Treatment in Attention-Deficit/Hyperactivity Disorder (ADHD): An Analysis of the MED-ADHD Repository of Randomised Controlled Trials

CNS Drugs. 2026 Aug 13. doi: 10.1007/s40263-026-01323-7. Online ahead of print.ABSTRACTBACKGROUND AND OBJECTIVE: Randomised controlled trials (RCTs) have demonstrated that pharmacotherapy reduces symptoms of attention-deficit/hyperactivity...

Resting-state functional connectivity of the sensorimotor network in medication-naive Chinese children with ADHD: cross-sectional associations with hyperactivity/impulsivity and executive function

Front Psychiatry. 2026 Jul 27;17:1843959. doi: 10.3389/fpsyt.2026.1843959. eCollection 2026.ABSTRACTBACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder, often-but not always-characterized by inattention, hyperactivity/impulsivity, and deficits...
close chatgpt icon
ChatGPT

Enter your request.

CME/CPD